Post-Market Follow-Up Study of Coroflex ISAR NEO Coronary Stent System in Patients with Coronary Artery Disease
Led by Fundación EPIC · Updated on 2026-10-21
3000
Participants Needed
26
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an international, multicenter, prospective, non-randomized observational study to confirm and support the clinical safety and performance of the Coroflex ISAR NEO coronary stent system. This study focuses on patients with coronary artery disease CAD or ischemic heart disease treated in real-world clinical settings to meet European Union Medical Device Regulation requirements for post-market follow-up. It involves consecutive patients treated with the sirolimus-eluting Coroflex ISAR NEO stent as intended by the manufacturer.
Participants receive the Coroflex ISAR NEO coronary stent system during their routine percutaneous coronary intervention PCI procedures. This study observes patients undergoing stent placement according to standard clinical recommendations, without randomization or specific treatment assignment. The study includes patients with new lesion lengths between 2 and 4 mm and follows them after stent implantation to monitor outcomes and device performance.
During the study, participants are monitored for safety and effectiveness outcomes including freedom from target lesion failure within seven days after the procedure. Additional assessments track potential complications during PCI such as accidental stent dislodgement, balloon or hypotube rupture, coronary perforation, dissection, no reflow, and thrombosis. Data collection continues according to clinical practice, with informed consent obtained and follow-up lasting up to the study completion date in February 2027.
CONDITIONS
Brief Title
Coroflex® ISAR NEO PMCF Study
Research Team
K
koldobika García San Román, MD, PhD
F
FUNDACION EPIC
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients must meet standard recommendations for Percutaneous Coronary Intervention (PCI) based on the latest European Society of Cardiology guidelines or have PCI planned as part of their treatment
Patients with new coronary lesion length between 2 and 4 millimeters
Signed informed consent
You will not qualify if you...
Patients who refuse to participate
Pregnant or lactating women
Patients with acute coronary syndrome in cardiogenic shock (Killip 4)
Patients with contraindications to anti-platelet or anti-coagulation therapy
Patients with lesions not suitable for successful PCI or stent implantation
Known sensitivity to sirolimus, Probucol, stent components, or contrast agents who cannot be premedicated
Patients with life expectancy less than 2 years
Participation in other clinical trials
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Procedure day and immediate post-procedure period
Participants receive the Coroflex® ISAR NEO coronary stent system during their routine percutaneous coronary intervention procedure.
Follow-up
Duration - At least 7 days
Participants are monitored for safety and effectiveness outcomes including freedom from target lesion failure and procedure-related complications for at least 7 days after stent placement.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Study of Erectile Function Changes After Coronary Intervention in Men With Heart Attack or Stable Angina
Comparing Intravascular Ultrasound-Guided and Experienced Angiography-Guided Stenting
for Left Main Coronary Artery Bifurcation Lesions
A Prospective Randomized Clinical Trial
Evaluating Myocardial Viability in Ischemic Heart Disease Using Integrated 18F-FDG PETMR Imaging Before Surgery
Effect of EA-230 on Hospital Stay Duration in Coronary Artery Disease Patients Undergoing Bypass Surgery
Evaluating a New Cardiac Rehabilitation Approach for Adults With Ischemic Heart Disease
A Prospective, Randomized Controlled Study Comparing New and Traditional Therapies
DELINEATE-Deploy Deep Learning for Echo Analysis, Tracking, and Evaluation - Prospective Deployment Platform IRB
Observational Study on Intracoronary Adenosine Use for Coronary Flow Reserve and Microcirculatory Resistance in Angina Patients
Phase 2a Study of SRSD107 Given by Injection in Adults With Chronic Coronary or Peripheral Arterial Disease
AI Facial Image Analysis to Screen for Coronary Artery Disease in Adults at High Risk from Community Settings
Study of AI-assisted Cardiac CT to Improve Risk Prediction and Outcomes in Adults with Coronary Artery Disease
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.